Best to Sell Stocks After This Yield-Curve Signal

Wall Street is waiting for the Fed minutes, due later today

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     8/21/2019
David Stockman: "We're on the verge of the worst American crisis in nearly a century…" ADebt is skyrocketing. The stock market is teetering on the edge. And Donald Trump is seeing his presidency self-destruct before his eyes. All of this adds up to a VERY dangerous situation for your wealth and your democracy. That's why former White House official David Stockman is sending out FREE copies of his urgent new book, Peak Trump: The Undrainable Swamp and The Fantasy of MAGA (a $26.99 value), today. Learn the truth before it's too late. See how to claim your FREE copy here.
Stock Futures Climb on Upbeat Retail Earnings By Patrick Martin Share On Dow Jones Industrial Average (DJI) futures are pointing to triple-digit gains this morning, getting a shot in the arm from a round of upbeat retail earnings. After the blue-chip index snapped its three-day winning streak yesterday, investor fears of a faltering domestic economy are being temporarily assuaged by blowout quarterly reports from Target (TGT) and Lowe's (LOW). Both retailers reported second-quarter earnings and same-store sales numbers that topped expectations, while TGT also upped its full-year profit guidance. Later today, Wall Street will eye release of the latest Fed meeting minutes, looking for clues about future monetary policy. Continue reading for more on today's market, including:  it's best to sell stocks after this yield-curve signal, according to Schaeffer's Senior Quantitative Analyst Rocky White. Options bulls piled on 2 pharma stocks that earned FDA nods. This Shake Shack bull signal has never been wrong. Plus, URBN rises despite mixed earnings; more opioid-related trouble for Cardinal Health; and Walmart sues Tesla. >> Continue reading...
LATEST HEADLINES
>> How to Trade the Yield Curve An increasing yield spread has historically marked a prime time to sell stocks >> Dow Snaps Win Streak as Tech, Financials Struggle Home Depot's earnings win couldn't boost the Dow >> Weight-Loss Drug Data Lifts Vivus Stock Above 200-Day One name is eyeing its biggest one-day percentage gain since last August >> FDA Nods Fuel Unusual Options Volume on NBRV, MRNA Call options are running much hotter than usual today >> Options Bulls Bet on a Bounce for Cigna Stock, Despite Dip Cigna stock is slightly lower on reports that it is selling its benefits insurance unit Sponsored If You Need Your Money in the Next 5 Years… America is at a crossroads. The middle-class is disappearing… government spending is out of control… and the implosion of Bubble Finance will cause the greatest market crash in history. So, if you need access to your nest egg in the next 5 years and can't afford another market crash it's time to take matters into your own hands. Find out what to do, right here.   Featured Stock Alert: AGGFF Recession Fears Sent Investors Scrambling...See Why!
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com